# Are Atrial Fibrillation Risk Loci Universally Applicable? Insights from Whole-Genome Sequencing in a Polish Population

**Authors:** Michał Wasiak, Mateusz Sypniewski, Paula Dobosz, Maria Stępień, Anna Michalska-Foryszewska, Patryk Rzońca, Zbigniew J. Król

PMC · DOI: 10.3390/medsci14010155 · Medical Sciences · 2026-03-21

## TL;DR

This study explores whether known genetic risk factors for atrial fibrillation apply to a Polish population using whole-genome sequencing.

## Contribution

The study is the first WGS-based investigation of AF susceptibility in a Polish population.

## Key findings

- No variants reached statistical significance for association with AF after multiple testing correction.
- Previously reported susceptibility loci were not replicated in this Polish cohort.
- Age was strongly associated with AF risk, but sex had no significant effect.

## Abstract

Background: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia worldwide and has a substantial genetic component. Genome-wide association studies (GWASs) have identified more than 100 susceptibility loci; however, replication across populations remains variable, suggesting potential population-specific differences in the genetic determinants of AF. To date, no whole-genome sequencing (WGS)-based study has evaluated AF susceptibility in a Polish population. Methods: We performed WGS (mean coverage 35×) in 233 unrelated individuals recruited within the Thousand Polish Genomes Project, including 56 patients with non-valvular AF and 177 controls without AF. After quality control and linkage disequilibrium pruning within a cardiovascular gene panel, 19,395 variants were analyzed. Association testing was performed using logistic regression adjusted for age and sex, applying both false discovery rate and Bonferroni correction thresholds. Results: No variants reached statistical significance for association with AF after correction for multiple evaluation. Previously reported susceptibility loci were not replicated in this cohort. Age was strongly associated with AF risk, whereas sex showed no significant effect. Given the relatively modest sample size, the study was primarily powered to detect variants with moderate or large effect sizes; smaller genetic effects reported in large GWASs may remain undetected. Conclusions: This pilot WGS-based study provides an initial exploration of AF-associated genetic variation in a Polish population. The absence of significant associations likely reflects the importance of further investigation in larger and well-characterized Central–Eastern European cohorts before genetic risk stratification approaches can be broadly applied across populations.

## Linked entities

- **Diseases:** Atrial fibrillation (MONDO:0004981)

## Full-text entities

- **Genes:** TTN (titin) [NCBI Gene 7273] {aka CMD1G, CMH9, CMPD4, CMYO5, CMYP5, EOMFC}, KCND3 (potassium voltage-gated channel subfamily D member 3) [NCBI Gene 3752] {aka BRGDA9, KCND3L, KCND3S, KSHIVB, KV4.3, SCA19}, NEBL (nebulette) [NCBI Gene 10529] {aka C10orf113, LASP2, LNEBL, bA165O3.1}, PITX2 (paired like homeodomain 2) [NCBI Gene 5308] {aka ARP1, ASGD4, Brx1, IDG2, IGDS, IGDS2}, HAND2 (heart and neural crest derivatives expressed 2) [NCBI Gene 9464] {aka DHAND2, Hed, Thing2, bHLHa26, dHand}, LMNA (lamin A/C) [NCBI Gene 4000] {aka CDCD1, CDDC, CMD1A, CMT2B1, EMD2, FPL}, ACTN1 (actinin alpha 1) [NCBI Gene 87] {aka BDPLT15}, ZFHX3 (zinc finger homeobox 3) [NCBI Gene 463] {aka ATBF1, ATBT, ATFB8, C16orf47, EIG20, SCA4}
- **Diseases:** hematological disorders (MESH:D006402), coronary artery disease (MESH:D003324), atrial remodelling (MESH:D064752), atrial cardiomyopathy (MESH:D009202), diabetes mellitus (MESH:D003920), cardiovascular diseases (MESH:D002318), obesity (MESH:D009765), kidney disease (MESH:D007674), heart disease (MESH:D006331), TIA (MESH:D002546), injury to (MESH:D014947), stroke (MESH:D020521), atrial thrombus (MESH:D013927), arrhythmia (MESH:D001145), structural (MESH:D020914), chronic kidney disease (MESH:D051436), dilated, hypertrophic, and left ventricular non-compaction cardiomyopathies (MESH:C565277), heart valve disease (MESH:D006349), congenital heart defects (MESH:D006330), thromboembolic (MESH:D013923), atrial hypertrophy (MESH:D006984), hypertension (MESH:D006973), heart failure (MESH:D006333), cancer (MESH:D009369), coronary disease (MESH:D003327), fibrosis (MESH:D005355), re-entrant arrhythmias (MESH:D013611), sleep apnoea (MESH:D012891), hyperlipidemia (MESH:D006949), AF (MESH:D001281)
- **Chemicals:** K-EDTA (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC13028008/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13028008/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC13028008/full.md

---
Source: https://tomesphere.com/paper/PMC13028008